We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Factory Location: 8 Shitingjiang Boulevard, Xinshi, Mianzhu, Deyang, Sichuan, China
Main Sales Markets: North America,Western Europe,Asia
Monthly Production Capacity: 500kg
Packaging Information: The inner package of 1kg is food packaging plastic bag, the outer package is aluminum foil bag；the inner package of 25kg is food packaging plastic bag, and the outer package is cardboard barrel
Delivery Lead Time: 1day
Sample Provided: yes
Payment Terms: L/C
【Product Name】Andrographolide
【Alias】Andrographis paniculata extract
【Active Ingredients】Andrographolide
【Purity】98%
【CAS】 5508-58-7
【Chemical Formula】C20H30O5
【Molecular Weight】304.25
【EINECS】226-852-5
【Botancial Source】Andrographis Wall. ex Nees
【Appearance Properties】White crystal powder
【Scope Of Application】Can be used in all kinds of medicine
【Description】
Andrographis is a genus of flowering plants in the acanthus family. They may be known generally as the false waterwillows, and several are called periyanagai.
Most species are native to Asia. Many are endemic to India. They may be herbs or shrubs.Some species are used medicinally. The best known is Andrographis paniculata, which is valued in Ayurveda, Unani, and Siddha medicine. It is used to treat a very long list of illnesses and conditions. A. alata and A. lineata are used in human and veterinary medicine.
Audited Supplier
Pharma Sources Insight JANUARY 2024
